We have located links that may give you full text access.
A Color- and Geometric-Feature-Based Approach for Denoising Three-Dimensional Cultural Relic Point Clouds.
Entropy 2024 April 6
In the acquisition process of 3D cultural relics, it is common to encounter noise. To facilitate the generation of high-quality 3D models, we propose an approach based on graph signal processing that combines color and geometric features to denoise the point cloud. We divide the 3D point cloud into patches based on self-similarity theory and create an appropriate underlying graph with a Markov property. The features of the vertices in the graph are represented using 3D coordinates, normal vectors, and color. We formulate the point cloud denoising problem as a maximum a posteriori (MAP) estimation problem and use a graph Laplacian regularization (GLR) prior to identifying the most probable noise-free point cloud. In the denoising process, we moderately simplify the 3D point to reduce the running time of the denoising algorithm. The experimental results demonstrate that our proposed approach outperforms five competing methods in both subjective and objective assessments. It requires fewer iterations and exhibits strong robustness, effectively removing noise from the surface of cultural relic point clouds while preserving fine-scale 3D features such as texture and ornamentation. This results in more realistic 3D representations of cultural relics.
Full text links
Related Resources
Trending Papers
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease.Pharmaceuticals 2024 March 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app